
Circulating IL-12 and response to therapy in HCV-infected patients: Potential biomarker for a non-favorable outcome?
Author(s) -
Reis Mitermayer
Publication year - 2013
Publication title -
frontiers in immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.646
H-Index - 124
ISSN - 1664-3224
DOI - 10.3389/conf.fimmu.2013.02.00392
Subject(s) - ribavirin , medicine , pegylated interferon , immunology , immune system , cytokine , cohort , hepatitis c virus , biomarker , hepatitis c , viral load , gastroenterology , virus , biology , biochemistry